JW Jungwo Pharmaceutical Fined 12.5 Billion KRW by National Tax Service

[Asia Economy Reporter Gong Byung-sun] JW Choongwae Pharmaceutical announced on the 25th that it was fined 12.5 billion KRW by the Seoul Regional Tax Office due to investigations on corporate tax and others conducted from 2016 to 2020.

This amount corresponds to 6.01% of its equity capital.